Related Experiment Video
Updated: Dec 6, 2025

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Myocardial contraction fraction predicts mortality for patients with hypertrophic cardiomyopathy
Hang Liao1, Ziqiong Wang1, Liming Zhao2
1Department of Cardiology, West China Hospital, Sichuan University, 37 Guo Xue Xiang, Chengdu, 610041, Sichuan Province, People's Republic of China.
Insights
Myocardial contraction fraction (MCF) predicts adverse outcomes in hypertrophic cardiomyopathy (HCM) patients. Higher MCF levels are associated with significantly lower risks of all-cause and HCM-related mortality, aiding clinical risk assessment.
Area of Science:
- Cardiology
- Biomedical Engineering
- Clinical Research
Background:
- Hypertrophic cardiomyopathy (HCM) is a significant cause of morbidity and mortality.
- Accurate risk stratification in HCM patients is crucial for effective clinical management.
- Novel volumetric measures may offer improved prognostic capabilities.
Purpose of the Study:
- To evaluate the Myocardial Contraction Fraction (MCF) as a predictor of adverse outcomes in patients with HCM.
- To assess the association between MCF and both all-cause and HCM-related mortality.
Main Methods:
- Retrospective cohort study involving 438 HCM patients.
- Myocardial Contraction Fraction (MCF), defined as stroke volume to myocardial volume, was analyzed.
- Association between MCF tertiles and primary (all-cause mortality) and secondary (HCM-related mortality) endpoints was assessed.
Main Results:
- During follow-up, 17.2% experienced all-cause mortality and 65.8% experienced HCM-related mortality.
- Mortality rates decreased significantly across increasing MCF tertiles (P trend < 0.05 for both endpoints).
- Higher MCF tertiles were independently associated with a substantially reduced risk of all-cause and HCM-related mortality (adjusted HRs < 0.26, P < 0.001).
Conclusions:
- Myocardial Contraction Fraction (MCF) is an independent predictor of adverse outcomes in HCM patients.
- MCF should be considered as a valuable tool for comprehensive risk assessment in clinical practice.
- This novel volumetric measure offers prognostic insights beyond traditional risk factors.
Abstract:
The myocardial contraction fraction (MCF: stroke volume to myocardial volume) is a novel volumetric measure of left ventricular myocardial shortening. The purpose of the present study was to assess whether MCF could predict adverse outcomes for HCM patients. A retrospective cohort study of 438 HCM patients was conducted. The primary and secondary endpoints were all-cause mortality and HCM-related mortality. The association between MCF and endpoints was analysed. During a follow-up period of 1738.2 person-year, 76 patients (17.2%) reached primary endpoint and 50 patients (65.8%) reached secondary endpoint. Both all-cause mortality rate and HCM-related mortality rate decreased across MCF tertiles (24.7% vs. 17.9% vs. 9.5%, P trend = 0.003 for all-cause mortality; 16.4% vs. 9.7% vs. 6.1%, P trend = 0.021 for HCM-related mortality). Patients in the third tertile had a significantly lower risk of developing adverse outcomes than patients in the first tertile: all-cause mortality (adjusted HR: 0.26, 95% CI: 0.12-0.56, P = 0.001), HCM-related mortality (adjusted HR: 0.17, 95% CI: 0.07-0.42, P < 0.001). At 1-, 3-, and 5-year of follow-up, areas under curve were 0.699, 0.643, 0.618 for all-cause mortality and 0.749, 0.661, 0.613 for HCM-related mortality (all P value < 0.001), respectively. In HCM patients, MCF could independently predict all-cause mortality and HCM-related mortality, which should be considered for overall risk assessment in clinical practice.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pathophysiology of Cardiac Performance
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

